The Bulletin
Men's Weekly


.

Concept Medical granted Investigational Device Exemption (IDE) approval for their Magic Touch Sirolimus Coated Balloon for the treatment of Below the Knee (BTK) Arterial Disease

  • Written by PR Newswire
Concept Medical granted Investigational Device Exemption (IDE) approval for their Magic Touch Sirolimus Coated Balloon for the treatment of Below the Knee (BTK) Arterial Disease

TAMPA, Fla., Feb. 13, 2023 /PRNewswire/ -- Concept Medical Inc. (CMI), on 9thFebruary 2023, received the Investigational Device Exemption (IDE) from the US FDA, for its Magic Touch Sirolimus Coated Balloon.

Magic Touch PTA has received US FDA IDE approval for its BTK indicationMagic Touch PTA has received US FDA IDE approval for its BTK indication

The Magic Touch PTA Sirolimus Coated Balloon Catheter is...